Patient-derived organoids potentiate precision medicine in advanced clear cell renal cell carcinoma

To investigate the role of patient-derived organoid (PDO) model in the precision medicine of advanced clear cell renal cell carcinoma (ccRCC), we retrospectively analyzed the clinical data of seven cases of ccRCC diagnosed by operation and pathology in Renji Hospital from September 2021 to September...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Yizheng, Wang, Bingran, Tao, Yiying, Xia, Jun, Yuan, Kedi, Zheng, Junhua, Zhai, Wei, Xue, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762875/
https://www.ncbi.nlm.nih.gov/pubmed/36544542
http://dx.doi.org/10.1093/pcmedi/pbac028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762875/
https://www.ncbi.nlm.nih.gov/pubmed/36544542
http://dx.doi.org/10.1093/pcmedi/pbac028

Ejemplares similares